Our Team
Prof. Graham Ball, CSO
Graham is a world leading experts in artificial intelligence in healthcare. He leads the development and use of the Intellomx ANN technology. He has over 25 years’ experience of mathematical modelling and bioinformatics experience in the application of bioinformatics techniques to big biological data. He is an experienced commercial project manager and has acted as the bioinformatics consultant on numerous projects in the AI and ML space as lead consultant.
Simon Haworth, Director
Simon is a serial entrepreneur whose experience includes technology innovation and investment in Cambridge UK, Boston USA and Wuhan China. Former founder of listed investment company IPSO Ventures PLC. Simon’s commercial skills complement Prof Ball’s technical expertise.
Dr. Bill Mason, Director
Bill gained his PhD in medicine from Trinity College, Cambridge, England. He has founded several successful high technology life science companies which have been sold to global corporate ventures in drug discovery, diagnostics and regenerative medicine; and advised a number of private equity investment firms. He has conducted over 100 transactions in healthcare and life sciences in the last 20years, working with a portfolio of quoted and unquoted life science companies.
Dr. Kurt Gehlsen, Advisor
Senior executive with 30+ years experience in private and public companies, pharmaceutical and medical device product development, basic research, clinical development, regulatory affairs, strategic planning, business development, early-stage investment and product development, company formation, investor relations and executive management.
Investors
Intellomx is supported by a range of private and public investors.
